secwatch.observer — SEC 8-K summary
======================================

Issuer:     Climb Bio, Inc. (CLYM)
CIK:        0001768446
Form:       8-K
Filed at:   2026-04-28T23:59:59+00:00
Accession:  0001193125-26-183711
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Climb Bio raises $110M in private placement of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Gross proceeds of ~$110M from 9.481M shares at $9.50 and 2.106M pre-funded warrants at $9.4999 each.
- Closing expected April 29; participants include RA Capital, Adage Capital, Cormorant, and others.
- Proceeds to fund late-stage development of budoprutug and CLYM116 for immune-mediated diseases.
- Company to file resale registration statement within 45 days after closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768446/000119312526183711/0001193125-26-183711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768446/000119312526183711/d153155d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-183711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer